Standard Biotools (LAB) Cash from Operations (2010 - 2026)

Standard Biotools (LAB) has 17 years of Cash from Operations data on file, last reported at 46597000.0 in Q1 2026.

• On a quarterly basis, Cash from Operations fell 53.87% year-over-year to 46597000.0 in Q1 2026; TTM through Mar 2026 was 90657000.0, a 18.52% increase from a year earlier, with the FY2025 full-year figure at 74343000.0, up 48.18% from the prior year.
• Cash from Operations for Q1 2026 stood at 46597000.0, down from 1190000.0 in the prior quarter.
• Over the last five years, Cash from Operations for LAB reached as high as 1190000.0 in Q4 2025 and fell as low as 62476000.0 in Q1 2024.
• Historically, Cash from Operations has averaged 23355941.18 across 5 years, with a median of 20668000.0 in 2025.
• Across the five-year window, Cash from Operations plunged 636.31% in 2024 and surged 91.54% in 2025, its largest moves.
• Year by year, Cash from Operations stood at 19181000.0 in 2022, then rose by 26.69% to 14061000.0 in 2023, then climbed by 0.01% to 14059000.0 in 2024, then jumped by 91.54% to 1190000.0 in 2025, then sank by 3815.71% to 46597000.0 in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were 46597000.0 in Q1 2026, 1190000.0 in Q4 2025, and 22202000.0 in Q3 2025.